Chitosan may decrease serum valproate and increase the risk of seizure reappearance

BMJ. 2009 Sep 24:339:b3751. doi: 10.1136/bmj.b3751.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Obesity Agents / adverse effects*
  • Anticonvulsants / blood
  • Anticonvulsants / therapeutic use*
  • Chitosan / adverse effects*
  • Dietary Supplements / adverse effects*
  • Drug Interactions
  • Epilepsy, Generalized / blood
  • Epilepsy, Generalized / drug therapy*
  • Female
  • Humans
  • Phenobarbital / blood
  • Phenobarbital / therapeutic use
  • Recurrence
  • Risk Factors
  • Valproic Acid / blood
  • Valproic Acid / therapeutic use*

Substances

  • Anti-Obesity Agents
  • Anticonvulsants
  • Valproic Acid
  • Chitosan
  • Phenobarbital